Topics

endocrine disruptor

October 9, 2018

FPF Workshop 2018: Improving chemical safety by new science

Presentations at Food Packaging Forum 2018 workshop cover predictive toxicology, computational methodologies, green chemistry
Reading time: 3 minutes

September 28, 2018

Regulatory relevance of nonmonotonic responses

Scientists discuss different cases of nonmonotonic dose-response curves and their relevance for regulatory decision-making; nonmonotonicity occurring at low doses challenges current approach to determining low-dose ‘safe’ exposure levels from high-dose toxicity testing
Reading time: 3 minutes

September 27, 2018

Prioritization of chemicals associated with plastic packaging

Phthalates in plastic packaging prioritized for further assessment of their impact on human health and the environment
Reading time: 1 minute

September 27, 2018

Chemicals in plastic packaging listed as potential EDCs

The Endocrine Disruption Exchange adds 26 substances used in plastic packaging to its list of potential endocrine disrupting chemicals
Reading time: 1 minute

September 25, 2018

EFSA BPA reevaluation: 1st meeting

EFSA’s CEP Panel Working Group on BPA safety reevaluation holds 1st meeting; minutes available online
Reading time: 1 minute

September 17, 2018

BPA substitutes and chromosomal abnormalities

Mice exposed to low doses of BPA, BPS, diphenyl sulfone, BPF, BPAF exhibit chromosomal abnormalities that persist for several generations, according to new study in Current Biology
Reading time: 2 minutes

September 14, 2018

CLARITY-BPA webinars: Key messages

Carnegie Mellon University and FDA hold webinars on CLARITY-BPA academic research and guideline studies; FDA upholds importance of high-dose effects; academic researchers highlight significant low-dose effects
Reading time: 2 minutes

September 13, 2018

BPA human study: Effects on insulin response

First experimental study in humans finds low-dose exposure to bisphenol A alters insulin response to oral and IV glucose, possibly increases diabetes 2 risk
Reading time: 2 minutes

September 12, 2018

Opinion: FDA ‘rushing to judgement’ on BPA

Article in Environmental Health News discusses main goal of CLARITY-BPA program and U.S. FDA’s premature conclusions on BPA hazards
Reading time: 2 minutes

September 11, 2018

Webinar on CLARITY-BPA core study

U.S. Food and Drug Administration hosts webinar on guideline studies conducted within CLARITY-BPA program, September 13, 2018; registration now open
Reading time: 1 minute
Scroll to Top